Mode
Text Size
Log in / Sign up

Observational report describes coinfections with monkeypox, HIV, and STIs in U.S. patients

Observational report describes coinfections with monkeypox, HIV, and STIs in U.S. patients
Photo by iMattSmart / Unsplash
Key Takeaway
Note descriptive report of monkeypox, HIV, and STI coinfection; evidence is observational and preliminary.

An observational report from eight U.S. jurisdictions described coinfections involving monkeypox, HIV, and sexually transmitted infections among persons diagnosed with monkeypox. The study type was observational, and the specific sample size, intervention or exposure, comparator, and primary outcome were not reported. The main result was a description of this coinfection pattern; no effect sizes, absolute numbers, p-values, or confidence intervals were provided.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported in the available information. The follow-up duration and specific study phase were also not reported.

Key limitations include the observational nature of the report, which precludes causal inference, and the absence of quantitative data on the frequency or strength of associations. The funding sources and potential conflicts of interest were not reported. The practice relevance is not explicitly stated, and clinicians should view this as a preliminary, descriptive observation that highlights a clinical scenario requiring further investigation rather than guiding immediate practice changes.

Study Details

EvidenceLevel 5
PublishedSep 2022
View Original Abstract ↓
This report describes people coinfected with Monkeypox, HIV, and STIs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.